August 10, 2018
- Drug Trial Snapshot: MULPLETA
- Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry (PDF - 145KB)
- FDA approves Onpattro (patisiran), first-of-its kind targeted RNA-based therapy to treat a rare disease
- Spotlight on CDER Science: New Class of Drugs Fulfills Promise of RNA-based Medicine
.png)
No hay comentarios:
Publicar un comentario